Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

600 public trials 70 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Active, Not Recruiting

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

NCT04904588

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +30 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Stanford University Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 39 locations
View Trial Details
Active, Not Recruiting

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

NCT06001385

Conditions
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +37 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Honor Health Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
View all 32 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Ponatinib Followed by Imatinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

NCT04070443

Conditions
BCR-ABL Positive Chronic Myelogenous Leukemia, Bone Marrow Diseases, Chronic Disease, +12 more
Locations
  • Chu Amiens Picardie Amiens, France
  • CHU d'Angers Angers, France
  • Centre Hospitalier Annecy-Genevois Annecy, France
  • CH d'Avignon Avignon, France
View all 28 locations
View Trial Details
Active, Not Recruiting

2nd or 3rd TKI-stop After 2 Years Nilotinib Pre-treatment in CML-patients

NCT02917720

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Baden-Wurttemberg, Germany
  • Universitätsmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
  • Klinikum rechts der Isar München, Bavaria, Germany
  • Medizinische Hochschule Hannover Hannover, North Rhine-Westphalia, Germany
View all 15 locations
View Trial Details

Related conditions